Pharma firms are pouncing on opportunity as patents on world’s second-bestselling drug, which goes by brand names Ozempic and Wegovy, are expiring in nearly 100 nations.
More episodes from "ThePrint"
Don't miss an episode of “ThePrint” and subscribe to it in the GetPodcast app.